Jenny C. Chang, MD

Projects

Projects per year 2010 2014 2016 2020 2045

• 23 Active
• 24 Not started
• 31 Finished

Projects per year

Search results

• Active

  IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES

  Mai, H. P., Abdelrahim, M., Chang, J. C., Ganguly, S., Heyne, K., Mathur, S., Niravath, P. A., Pingali, S. R., Shah, S., Sun, K., Venta, L. A. & Zhang, J.

  6/19/24 → …

  Project: Clinical Trial

• REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

  Niravath, P. A., Antosh, D., Chang, J. C., High, R. A., Mai, H. P., Singh, M., Sun, K. & Zaid, T.

  5/17/24 → …

  Project: Clinical Trial

• Breast Cancer Screening & Diagnostics for Black Individuals in the Houston Area (Susan G. Komen)

  Chang, J. C.

  1/1/24 → 12/31/24

  Project: Non Profit

• Dual targeting of PI3K and NOS pathways in Metaplastic Breast Cancer (MBC)

  Chang, J. C.

  7/8/23 → 6/30/28

  Project: Federal Funding Agencies

• Targeting Nitric Oxide Synthase (NOS) pathway to remodel obesity induced tumor inflammation in patients with TNBC

  Chang, J. C.

  12/1/22 → 11/30/24

  Project: State

• A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)

  Chang, J. C.

  6/10/22 → 5/31/27

  Project: Federal Funding Agencies

• Fulvestrant Plus Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

  Chang, J. C., Mai, H. P., Mathur, S., Niravath, P. A. & Sun, K.

  7/15/21 → …

  Project: Clinical Trial

• Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

  Chang, J. C., Mai, H. P., Niravath, P. A. & Sun, K.

  2/9/21 → …

  Project: Clinical Trial

• Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis

  Wong, S. T., Chang, J. C. & Sheng, J.

  9/15/20 → 8/31/25

  Project: Federal Funding Agencies

• Convergent AI for Precise Breast Cancer Risk Assessment

  Wong, S. T., Chang, J. C. & Ensor, Jr., J. E.

  6/1/20 → 5/31/25

  Project: Federal Funding Agencies

• Sample and Data Collection for Houston Methodist Cancer Center Research

  Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.

  4/9/20 → …

  Project: Clinical Trial

• ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

  Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.

  3/6/20 → 3/5/45

  Project: Non Profit

• CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.

  Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.

  3/6/20 → 3/5/45

  Project: Non Profit

• Imaging the mechanical microenvironment in cancers using ultrasound

  Chua, C. Y. X. & Chang, J. C.

  3/1/20 → 2/28/25

  Project: Federal Funding Agencies

• Novel potential drug targets for treatment of triple negative breast cancer

  Chang, J. C. & Rosato, R. R.

  10/1/19 → 9/30/25

  Project: Non Profit

• NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

  Geyer, C. E., Niravath, P. A., Chang, J. C. & Darcourt, J.

  3/12/19 → 2/28/25

  Project: Non Profit

• TAILOR RT: A RANDOMIZED TRIAL OF REGIONAL RADIOTHERAPY IN BIOMARKER LOW RISK NODE POSITIVE AND T3N0 BREAST CANCER

  Teh, B. S., Chang, J. C., Farach, A. M., Haque, W. M., Morgan, P. B., Niravath, P. A., Shadle, K. M., Shkedy, C. & Singh, M.

  5/30/18 → 5/29/28

  Project: Non Profit

• A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL

  Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.

  12/8/16 → 12/7/41

  Project: Non Profit

• EAY131 - Molecular Analysis for Therapy Choice (MATCH)

  Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.

  9/20/16 → 9/20/41

  Project: Federal Funding Agencies

• Stem Cell: Biomarkers Including Putative Stem Cells Markers in Human Breast Cancers

  Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.

  3/20/14 → …

  Project: Clinical Trial

• Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS

  Chang, J. C., Niravath, P. A. & Singh, M.

  3/20/14 → …

  Project: Clinical Trial

• A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB

  Chang, J. C. & Singh, M.

  University of Michigan

  6/29/12 → 3/22/37

  Project: Federal Funding Agencies

• NSABP43; NSABP47; ECOG 2108

  Chang, J. C.

  "NSABP Foundation, Inc"

  3/1/11 → 3/25/26

  Project: Non Profit